Invention Application
US20110014154A1 Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors
有权
芳香杂环稠合吲哚并苯二氮卓HCV NS5B抑制剂
- Patent Title: Aromatic Heterocyclic Fused Indolobenzadiazepine HCV NS5B Inhibitors
- Patent Title (中): 芳香杂环稠合吲哚并苯二氮卓HCV NS5B抑制剂
-
Application No.: US12922801Application Date: 2009-03-24
-
Publication No.: US20110014154A1Publication Date: 2011-01-20
- Inventor: John A. Bender , Zhong Yang , John F. Kadow
- Applicant: John A. Bender , Zhong Yang , John F. Kadow
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- International Application: PCT/US2009/038010 WO 20090324
- Main IPC: A61K31/5517
- IPC: A61K31/5517 ; C07D487/14 ; A61K38/21 ; A61K38/20 ; A61K38/13 ; A61P31/14
Abstract:
The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
Public/Granted literature
- US08431568B2 Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors Public/Granted day:2013-04-30
Information query
IPC分类:
